Nope. Got everything done I had to.

New Post Public Reply Private Reply Replies (0) Message Board
joey68 joey68 #309
217
Nope. Got everything done I had to.
View My Board Here:
http://investorshangout.com/Joeys-Investment-Board-91611/


Invite Only

There is a VERY HIGH degree of RISK involved in trading and investing. Only invest what you can afford to lose.

Disclaimer:
As used herein, the terms "You" and "Your" shall mean you, individually, the reader, and each other party on whose behalf you may use the contained information at any time.
All references to "My", "I", and “The writer of the above post” shall refer to the creator of the username Joey68.

Do NOT invest unless you are prepared to sustain a total loss of the money you have invested plus any commission or other transaction charges.

There is a very high degree of risk involved in trading and investing. Past results are not indicative of future returns. I assume no responsibility for your trading and investment results. You should NOT rely on the information in the above post to make any decision or take any action.

ALL OF MY STATEMENTS, including but not limited to, POSTS, MESSAGES, PRIVATE MESSAGES, and RESPONSES are OPINION and NOT fact and are for entertainment purposes only. Do your own research and make your own decisions based on your own conclusions.
ALL OF MY STATEMENTS, including but not limited to, POSTS, MESSAGES, PRIVATE MESSAGES, and RESPONSES are NOT advice, and are NOT designed to substitute the expertise and judgment of a professional. It is your responsibility to seek investment advice during all stages of your investments. It is your responsibility to evaluate the accuracy, completeness and usefulness of the information in the above post.
I am NOT a professional.
I do NOT work for you.
My posts are NOT investment advice. I am not paid to post.
There is no correlation between the number of posts I write per day and your assumed success of a company.
It is NOT my responsibility to inform you of my own personal investment decisions.
It is NOT my responsibility to inform you when it is time for you to buy, hold, and/or sell a position.
I have no control over, and am not responsible for the actions of others who copy, store, edit, change, prepare any derivative work of or alter in any way any of the content provided in my posts.
Errors and Omissions expected. The writer of the above post accepts no liability or responsibility for any errors or omissions contained in the above post or contained within this Disclaimer.
The writer of the above post shall NOT accept any liability for the accuracy or completeness of the information contained in the above post, for any reliance placed by any person on the information contained in the above post, or for any damage or loss, however caused, in connection with the use or reliance on any information contained in the above post.
The above post may contain links to websites owned and operated by third parties. These links are provided for informational purposes only and are NOT endorsed by the writer of the above post. The writer of the above post has no control over the contents of any linked website and bears no responsibility for the accuracy, legality, or content of the external site or for that of subsequent links.
YOU ACCESS ALL LINKS ENTIRELY AT YOUR OWN RISK.
The writer of the above post makes no warranties or representations, express or implied about such linked websites, the third parties they are owned and operated by, or the information contained on these websites.
The writer of the above post accepts no liability for any damage or loss, however caused, in connection with the use of or reliance on any information, material, products, or services contained on or accessed through any such linked websites.

There is a VERY HIGH degree of RISK involved in trading and investing. Only invest what you can afford to lose.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

J&J's New Study: Sjögren’s Solution Insight Sparks Debate

Updated Category News Views 53

Patient-Centric Take on Sjögren's Disease Johnson & Johnson has dropped fresh Phase 2 results on nipocalimab, reminding everyone they're at the helm of reshaping treatments for Sjögren's disease (SjD). A condition leaving about four million folks craving better days, in multiple ways, shines a light on what's gripping patients the hardest. It's hard not to sit up and...

Continue Reading
Interface Faces Sales Outlook Investigation Storm

Updated Category News Views 67

A Shift That Rattled Investors Interface's recent tumble in the market wasn't just a quick slip; it was a full-on somersault. The company's revised sales outlook for 2026 turned out to be a real doozy, firing up the sniffer dogs at SueWallSt into an investigation. If you've been holding onto those NASDAQ:TILE shares, this might just be the type of headache you'd want to...

Continue Reading
Everest Group Faces Major Class Action Deadline Looms

Updated Category News Views 128

Everest Group's Headaches Multiply as Deadline Approaches Well, here we find a classic case of Wall Street drama—Everest Group, Ltd. (NYSE:EG), a company whose troubles would make any trader weary. As of late, it's caught up in a nasty class-action lawsuit with stakes high enough to raise eyebrows from Broadway to Bayou. Investors in Everest better be tuned in, because...

Continue Reading
Tiana Marbuery Joins ALTA Division at Partner

Updated Category News Views 197

Tiana Marbuery Dives In at Partner Forget flashy office parties and buzzword bingo. Today’s gig's all about substance. Partner Engineering and Science, Inc. just snagged themselves a heavy-hitter with Tiana Marbuery joining the ranks as Technical Director in their ALTA Division. This ain't a small fry deal—Marbuery's packing over eight years of hard-earned chops in...

Continue Reading
Harborside Inn Rebuilding: A Boost for Block Island

Updated Category News Views 87

A Fire Sparks New Beginnings on Block Island When the Harborside Inn went up in flames in August 2023, it left a gaping hole in Block Island's hospitality scene. Now, rising from the ashes, this landmark hotel is set for a major comeback, thanks to a hefty $8.5 million financing deal with The Washington Trust Company. It's a rebirth that's about more than just bricks and...

Continue Reading
Datavault AI's Turbulent Boardroom Saga Escalates

Updated Category News Views 166

The Corporate Chess Game at Datavault AI If there's one thing Wall Street hates, it's uncertainty. And boy, does Datavault AI (NASDAQ: DVLT) deliver plenty of it right now. Founder Nathaniel Bradley has lobbed a lawsuit at the board, claiming that Chairman and CFO Brett Moyer orchestrated a coup to oust him without proper board procedures. Talk about drama fit for a soap...

Continue Reading
McKinley Irvin Earns Top 2027 Rankings in Family Law

Updated Category News Views 103

A Legal Eagle Soars High in 2027 Oh, the legal world can be as cutthroat as the stock market some days, especially when you're gunning for those top-tier rankings. This year, McKinley Irvin has managed to ruffle a few feathers in the Pacific Northwest, claiming top honors in the 2027 Best Law Firms rankings. And let me tell you, this wasn’t just handed to them on a...

Continue Reading
JOYEE N01 Kicks Off Global Launch with African Orders

Updated Category News Views 92

A New Chapter for JOYEE N01 There's a moment in every company's life when it either steps boldly into the future or stumbles back into obscurity. For FAW Bestune, October 28, 2026, was one of those defining moments. On this day, they launched global mass production of the JOYEE N01 in Yancheng, China. And boy, did they pull out all the stops—you don't see this kind of...

Continue Reading
Trucordia Expands BYU Sponsorship with Helmet Branding

Updated Category News Views 138

Trucordia Gets Visible with BYU Football Alright, BYU fans and insurance buffs, here's your latest play-by-play. Trucordia, a major player in the insurance game, is ratcheting up its visibility in the college sports scene. They've struck gold with a multiyear sponsorship deal putting their logo on Brigham Young University's (BYU) football helmet bumpers. Talk about a...

Continue Reading
AXON Revenue Forecast Cut Spurs Legal Investigation

Updated Category News Views 135

Axon's Revenue Forecast Takes a Hit Listen up, folks. Axon Enterprise, Inc. (NASDAQ: AXON) has stirred the pot, cutting their 2026 revenue forecast faster than you can say "counter-drone deployment." Back in August, they were riding high on their second-quarter call, raising their growth forecast to a cheerful 32%-34%. Fast forward to November, and it's been slashed to...

Continue Reading

Top 5 Most Recently Viewed Articles

Solid Earnings Results Boost Market Confidence and Growth

Updated Category News Views 192

Positive Market Response to Earnings Reports The recent earnings reports from various companies have exceeded expectations, sparking renewed enthusiasm in the market. For instance, Taiwan Semiconductor (NASDAQ: TSM) has reported impressive earnings, significantly bolstering the narrative surrounding AI technology. As a result, TSM shares surged by 6% and have gained 14%...

Continue Reading
BizClik Media Debuts April Editions of Leading Tech Magazines

Updated Category News Views 337

BizClik Media Unveils April Editions of Technology Publications BizClik Media has recently launched exciting new editions of its esteemed technology magazines, providing a wealth of insights and interviews with influential leaders. These editions focus on pivotal topics such as artificial intelligence, sustainability, quantum computing, and future-ready infrastructure....

Continue Reading
Infosys Elevates ABN AMRO's Lending Operations with nCino

Updated Category News Views 197

Transforming Lending Operations Infosys, a global leader in next-generation digital services and consulting, has made significant strides in enhancing ABN AMRO's lending process by implementing the innovative nCino platform. This collaboration seeks to unify various legacy systems into a singular, seamless framework, revolutionizing how ABN AMRO manages loan origination...

Continue Reading
Statkraft's Strategic Sale of Renewable Assets in the Netherlands

Updated Category News Views 179

Statkraft Finalizes Sale of Renewable Energy Operations Statkraft, recognized as Europe’s leading producer of renewable energy, has recently completed the sale of its renewable energy development business in the Netherlands. In this significant move, the Dutch renewable energy company Greenchoice has acquired an operational solar portfolio boasting a capacity of 120...

Continue Reading
Canadian Immigration Policy Changes and Economic Forecast Insights

Updated Category News Views 242

Understanding Canada's Recent Immigration Targets In recent discussions surrounding economic policies, Canada's new immigration targets have come into the spotlight. As announced this week, these revised targets are set to significantly influence various aspects of the economy, particularly the projections made by the Bank of Canada. Implications for Economic Growth...

Continue Reading